{"entity":{"id":"steven-clifford","kind":"person","name":"Steven Clifford","aka":[],"tldr":"Medulloblastoma biologist whose molecular subgrouping work underpins risk-adapted treatment of childhood brain tumours; directs Newcastle University's cancer centre.","summary":"Steven Clifford is Director of the Newcastle University Centre for Cancer and Chair of Molecular Paediatric Oncology. His research has defined molecular subgroups and prognostic biomarkers of medulloblastoma, the most common malignant childhood brain tumour, informing risk stratification in European SIOP trials and clinical guidelines. The centre works alongside the Northern Centre for Cancer Care at Newcastle Hospitals NHS Foundation Trust.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.ncl.ac.uk/cancer/about-us/leadership-team/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Clifford+SC%5BAuthor%5D"}],"tags":["leadership","clinician-scientist","paediatric oncology","neuro-oncology"],"related":[],"cancers":["medulloblastoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["newcastle-cancer-centre"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Chair of Molecular Paediatric Oncology and Director, Newcastle University Centre for Cancer","institutionId":"newcastle-cancer-centre","specialisms":["Medulloblastoma","Paediatric neuro-oncology","Molecular classification","Biomarkers"],"profiles":[{"label":"Institution profile","url":"https://www.ncl.ac.uk/cancer/about-us/leadership-team/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Clifford+SC%5BAuthor%5D"}],"papers":[{"title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","journal":"Lancet Oncology","year":2017,"url":"https://doi.org/10.1016/S1470-2045(17)30243-7","doi":"10.1016/S1470-2045(17)30243-7"},{"title":"EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma","journal":"Lancet Oncology","year":2019,"url":"https://doi.org/10.1016/S1470-2045(19)30669-2","doi":"10.1016/S1470-2045(19)30669-2"},{"title":"Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial","journal":"Lancet Oncology","year":2018,"url":"https://doi.org/10.1016/S1470-2045(18)30532-1","doi":"10.1016/S1470-2045(18)30532-1"}]},"route":"/people/steven-clifford/","neighbours":{"cancer":[{"id":"medulloblastoma","kind":"cancer","name":"Medulloblastoma","route":"/cancers/medulloblastoma/"}],"institution":[{"id":"newcastle-cancer-centre","kind":"institution","name":"Newcastle Cancer Centre / Northern Centre for Cancer Care","route":"/institutions/newcastle-cancer-centre/"}]}}